Skip to main content

and
  1. No Access

    Article

    Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group

    M A Hoechstetter, R Busch, B Eichhorst, A Bühler, D Winkler, M J Eckart in Leukemia (2017)

  2. Article

    Open Access

    Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

    Chronic myeloid leukemia (CML)-study IV was designed to explore whether treatment with imatinib (IM) at 400 mg/day (n=400) could be optimized by doubling the dose (n=420), adding interferon (IFN) (n=430) or cytar...

    R Hehlmann, M Lauseker, S Saußele, M Pfirrmann, S Krause, H J Kolb, A Neubauer in Leukemia (2017)

  3. Article

    Open Access

    Condensed versus standard schedule of high-dose cytarabine consolidation therapy with pegfilgrastim growth factor support in acute myeloid leukemia

    The aim of this cohort study was to compare a condensed schedule of consolidation therapy with high-dose cytarabine on days 1, 2 and 3 (HDAC-123) with the HDAC schedule given on days 1, 3 and 5 (HDAC-135) as w...

    S Jaramillo, A Benner, J Krauter, H Martin, T Kindler, M Bentz in Blood Cancer Journal (2017)

  4. No Access

    Article

    Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)

    Primary mediastinal B-cell lymphoma (PMBL) is an aggressive extranodal B-cell non-Hodgkin's lymphoma with specific clinical, histopathological and genomic features. To characterize further the genotype of PMBL...

    S Wessendorf, T F E Barth, A Viardot, A Mueller, H A Kestler, H Kohlhammer in Leukemia (2007)

  5. No Access

    Article

    High incidence of trisomies 1q, 9q, and 11q in multiple myeloma: results from a comprehensive molecular cytogenetic analysis

    P Liebisch, C Wendl, A Wellmann, A Kröber, G Schilling, H Goldschmidt in Leukemia (2003)

  6. No Access

    Article

    DNA microarray analysis in malignant lymphomas

    Recently, DNA microarray technology has opened new avenues for the understanding of lymphomas. By hybridization of cDNA to arrays containing >10,000 different DNA fragments, this approach allows the simultaneo...

    C. Schwaenen, S. Wessendorf, H. A. Kestler, H. Döhner, P. Lichter in Annals of Hematology (2003)

  7. No Access

    Article

    Klassische und molekulare Zytogenetik in der Hämatologie und Onkologie

    K. Döhner, S. Stilgenbauer, S. Fröhling, M. Bentz, H. Döhner in Der Onkologe (2001)

  8. No Access

    Article

    Detection of secondary genetic aberrations in follicle center cell derived lymphomas: assessment of the reliability of comparative genomic hybridization and standard chromosome analysis

    Secondary chromosomal aberrations in follicle center cell derived lymphomas (FCDL) usually involve gains and losses of genetic material and may be an important prognostic value. In the present study, we aimed ...

    A Viardot, JI Martin-Subero, R Siebert, S Harder, S Gesk, M Bentz in Leukemia (2001)

  9. No Access

    Article

    BCL10 is not the gene inactivated by mutation in the 1p22 deletion region in mantle cell lymphoma

    The BCL10 gene has recently been cloned from the 1p22 breakpoint of the translocation t(1;14)(p22;q32) observed in mucosa-associated lymphoid tissue (MALT) lymphoma. BCL10 was shown to be a proapoptotic-signaling...

    L Bullinger, E Leupolt, C Schaffner, D Mertens, M Bentz, P Lichter, H Döhner in Leukemia (2000)

  10. No Access

    Article

    Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia

    Deletions affecting the long arm of chromosome 6 (6q) are among the most commonly observed chromosomal aberrations in lymphoid malignancies and have been identified as adverse prognostic factor in subsets of t...

    S Stilgenbauer, L Bullinger, A Benner, K Wildenberger, M Bentz, K Döhner, AD Ho in Leukemia (1999)

  11. No Access

    Article

    Molecular cytogenetic analysis of B-cell chronic lymphocytic leukemia

     The genetic alterations underlying the pathogenesis of B-cell chronic lymphocytic leukemia (B-CLL) are difficult to assess. Cytogenetic studies are hindered by the low in vitro mitotic activity of the tumor c...

    S. Stilgenbauer, K. Döhner, M. Bentz, P. Lichter, H. Döhner in Annals of Hematology (1998)

  12. No Access

    Chapter and Conference Paper

    Molecular Cytogenetic Analysis of Low-Grade B-Cell Neoplasias: a Comparative Genomic Hybridization Study

    Malignant tumors are characterized by deregulation of cell proliferation and differentiation, often induced by genomic alterations within the tumor cells (see Fischer et al., this volume). In acute leukemias, ...

    C. A. Werner, H. Döhner, T. F. E. Barth in Advances in Hematopoietic Stem Cell Transp… (1998)

  13. No Access

    Chapter and Conference Paper

    Fluorescence In Situ Hybridization for the Diagnosis and Follow-up of BCR-ABL Positive ALL

    The BCR-ABL fusion, which is the molecular counterpart of the t(9;22), is the most common genetic abnormality in adult acute lymphoblastic leukemia (ALL) [1]. Due to its important diagnostic and prognostic sig...

    G. P. Cabot, M. Bentz, K. Fischer, A. Ganser, M. Moos, C. Scholl in Acute Leukemias V (1996)

  14. No Access

    Chapter and Conference Paper

    Designing Probe Sets for the Detection of Chromosome Abnormalities in Acute Myeloid Leukemia Using Fluorescence In Situ Hybridization

    In recent years, the karyotype as a prognostic factor in acute myeloid leukemia (AML) has gained considerable interest. Clonal chromosome aberrations are identified in 50–60% of patients with AML (for review s...

    K. Fischer, C. Scholl, G. Cabot, M. Moos, R. Schlenk, P. Theobald in Acute Leukemias V (1996)

  15. No Access

    Chapter and Conference Paper

    Detection of Chromosomal Abnormalities on Previously Stained Peripheral Blood and Bone Marrow Smears

    Many hematological malignancies are associated with chromosomal aberrations that, in part, have important clinical significance. The detection of these abnormalities depends on the careful analysis of adequate...

    M. Bentz, H. Döhner, M. Schröder, S. Pohl, P. Lichter in Acute Leukemias IV (1994)

  16. Article

    Abstract

    Ch. Mache, Ch. Urban, H. Sauer, G. Brandesky, H. Meßner in Annals of Hematology (1992)